LIMA1 and gastric cancer: A second smaller cohort containing clinical information of gastric cancer patients treated with NAC (n = 78) and normal tissues (n = 80) was utilised to explore the implications of EPLIN expression in patients with NAC, demonstrating the association between EPLIN expression and the clinical pathologic features among these patients.